Related Experiment Video
Updated: Jul 31, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Acute coronary syndromes: 1. The platelet's role
D J Schneider1, P B Tracy, B E Sobel
1University of Vermont, Burlington, USA.
Hospital Practice (1995)
|April 2, 1998
Summary
Platelets are crucial for stopping bleeding but can also block blood flow without vessel damage. Understanding platelet behavior may improve treatments for heart attack and angina.
Area of Science:
- Cardiovascular Biology
- Hematology
- Thrombosis Research
Background:
- Platelets are essential for hemostasis and responding to vascular injury.
- Pathological thrombi, independent of vessel damage, can impede or occlude blood flow.
- Platelet dysfunction contributes to thrombotic cardiovascular events.
Purpose of the Study:
- To elucidate the complex roles of platelet pathophysiology in vascular and thrombotic diseases.
- To investigate mechanisms of thrombus formation in non-injury related scenarios.
- To identify potential therapeutic targets for cardiovascular syndromes involving platelets.
Main Methods:
- Review of current literature on platelet function and thrombosis.
- Analysis of clinical data related to myocardial infarction and unstable angina.
- Exploration of molecular pathways involved in platelet activation and aggregation.
Main Results:
- Platelet activation can occur independently of significant vascular damage.
- Thrombi formed under these conditions pose a risk of circulatory obstruction.
- Specific platelet pathways are implicated in the progression of cardiovascular syndromes.
Conclusions:
- A deeper comprehension of platelet pathophysiology is vital for advancing cardiovascular medicine.
- Targeting platelet hyperactivity may offer novel therapeutic strategies.
- Improved understanding promises better management of myocardial infarction and related conditions.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...